Skip to main content
OpenTrials

Clinical trial condition

Anemia, Refractory, with Excess of Blasts

Explore clinical trials studying Anemia, Refractory, with Excess of Blasts. Study availability and eligibility vary by location and protocol.

244 public trials 36 recruiting studies
Refine in advanced search Browse all conditions

Anemia, Refractory, with Excess of Blasts trial results

Completed

S9920 Busulfan Compared With Cyclophosphamide in Patients Undergoing Total-Body Irradiation Plus Peripheral Stem Cell Transplantation for Advanced Myelodysplastic Syndrome or Related Acute Myeloid Leukemia

NCT00005866

Conditions
Anemia, Anemia, Refractory, Anemia, Refractory, with Excess of Blasts, +14 more
Locations
  • Good Samaritan Medical Center Phoenix, Arizona, United States
  • Arizona Cancer Center Tucson, Arizona, United States
  • University of Arkansas for Medical Sciences Little Rock, Arkansas, United States
  • Alta Bates Comprehensive Cancer Center Berkeley, California, United States
View all 66 locations
View Trial Details
Completed

S0020 Immunosuppressive Therapy in Treating Patients With Myelodysplastic Syndrome

NCT00016419

Conditions
Anemia, Anemia, Refractory, Anemia, Refractory, with Excess of Blasts, +7 more
Locations
  • MBCCOP - Gulf Coast Mobile, Alabama, United States
  • CCOP - Greater Phoenix Phoenix, Arizona, United States
  • Veterans Affairs Medical Center - Phoenix (Carl T. Hayden) Phoenix, Arizona, United States
  • Veterans Affairs Medical Center - Tucson Tucson, Arizona, United States
View all 94 locations
View Trial Details
Completed

A Pilot Study to Evaluate the Co-Infusion of Ex Vivo Expanded Cord Blood Cells With an Unmanipulated Cord Blood Unit in Patients Undergoing Cord Blood Transplant for Hematologic Malignancies

NCT00343798

Conditions
Accelerated Phase Chronic Myelogenous Leukemia, Acute Myeloid Leukemia With Multilineage Dysplasia Following Myelodysplastic Syndrome, Adult Acute Lymphoblastic Leukemia in Remission, +145 more
Locations
  • City of Hope Medical Center Duarte, California, United States
  • University of Colorado Cancer Center - Anschutz Cancer Pavilion Aurora, Colorado, United States
  • University of Colorado Denver, Colorado, United States
  • Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium Seattle, Washington, United States
View Trial Details
Completed

Safety Study of Human Myeloid Progenitor Cells (CLT-008) After Cord Blood Transplant for Hematologic Malignancy

NCT00891137

Conditions
Anemia, Anemia, Refractory, Anemia, Refractory, with Excess of Blasts, +59 more
Locations
  • Children's Hospital of Orange County Orange, California, United States
  • Alfred I. duPont Hospital for Children Wilmington, Delaware, United States
  • Children's National Medical Center Washington D.C., District of Columbia, United States
  • Loyola University Medical Center, Cardinal Bernardin Cancer Center Maywood, Illinois, United States
View Trial Details

Related conditions